Stock Events

Stock Events

Terns Pharmaceuticals (430.F) Q3 2024 Earnings

5AugConfirmed

Q4 2023

Q2 2024

Q3 2024

-0.32

-0.3

-0.28

-0.27

Details

Expected EPS

-0.30952774159999996

Actual EPS

-0.282968

Surprise EPS

0.03

Surprise Percent

+8.58%

Description

Terns Pharmaceuticals (430.F) has reported earnings of -0.282968 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.